Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
Blueprint Medicines (NASDAQ: BPMC) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management will engage in a fireside chat scheduled for Monday, April 7, 2025, at 12:45 p.m. ET.
Investors and interested parties can access a live webcast of the presentation through Blueprint Medicines' website's Investors & Media section. The presentation recording will remain accessible on the company's website for 30 days following the event.
Blueprint Medicines (NASDAQ: BPMC) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. La direzione dell'azienda parteciperà a una chiacchierata informale programmata per lunedì 7 aprile 2025, alle 12:45 ET.
Investitori e parti interessate possono accedere a un webcast dal vivo della presentazione attraverso la sezione Investitori & Media del sito web di Blueprint Medicines. La registrazione della presentazione rimarrà accessibile sul sito dell'azienda per 30 giorni dopo l'evento.
Blueprint Medicines (NASDAQ: BPMC) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham. La dirección de la empresa participará en una charla informal programada para el lunes 7 de abril de 2025, a las 12:45 p.m. ET.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Inversores y Medios en el sitio web de Blueprint Medicines. La grabación de la presentación permanecerá accesible en el sitio web de la empresa durante 30 días después del evento.
Blueprint Medicines (NASDAQ: BPMC)는 제24회 니드햄 가상 의료 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 경영진은 2025년 4월 7일 월요일 오후 12시 45분 ET에 예정된 대화에 참여할 것입니다.
투자자 및 관심 있는 분들은 Blueprint Medicines 웹사이트의 투자자 및 미디어 섹션을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표 녹화는 이벤트 후 30일 동안 회사 웹사이트에서 계속 이용할 수 있습니다.
Blueprint Medicines (NASDAQ: BPMC) a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé. La direction de l'entreprise participera à une discussion informelle prévue pour le lundi 7 avril 2025, à 12h45 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Investisseurs & Médias du site Web de Blueprint Medicines. L'enregistrement de la présentation restera accessible sur le site de l'entreprise pendant 30 jours après l'événement.
Blueprint Medicines (NASDAQ: BPMC) hat seine bevorstehende Teilnahme an der 24. jährlichen Needham virtuellen Gesundheitskonferenz angekündigt. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Montag, den 7. April 2025, um 12:45 Uhr ET geplant ist.
Investoren und Interessierte können über den Bereich Investoren & Medien auf der Website von Blueprint Medicines auf ein Live-Webcast der Präsentation zugreifen. Die Aufzeichnung der Präsentation bleibt für 30 Tage nach der Veranstaltung auf der Website des Unternehmens verfügbar.
- None.
- None.
A live webcast of the presentation will be available by visiting the Investors & Media section of Blueprint Medicines' website at http://ir.blueprintmedicines.com. A replay of the webcast will be archived on Blueprint Medicines' website for 30 days following the presentation.
About Blueprint Medicines
Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success with two approved medicines, including AYVAKIT®/AYVAKYT® (avapritinib) which we are bringing to patients with systemic mastocytosis (SM) in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-24th-annual-needham-virtual-healthcare-conference-302411391.html
SOURCE Blueprint Medicines Corporation
FAQ
When is Blueprint Medicines (BPMC) presenting at the Needham Healthcare Conference 2025?
How can investors watch Blueprint Medicines' (BPMC) Needham Conference presentation?
How long will BPMC's Needham Conference presentation replay be available?
What type of presentation will BPMC deliver at the 2025 Needham Healthcare Conference?
